Endocrinology Medical News about Thyroid Remnant Dose

Your Unread Messages

See All

Hello, Mary O'connor
Manage E-mail | Logout

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease

3. Rapid correction of low vitamin D status in nursing home residents

4. 2008 Exclusive Survey—Earnings: Good news for primary care income

5. Medicare pay-for-reporting effort draws fire from frustrated doctors

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Thyroid Remnant Dose: 124I-PET/CT Dosimetric Comparison of rhTSH versus Thyroid Hormone Withholding Before Radioiodine Remnant Ablation in Differentiated Thyroid Cancer
Experimental and Clinical Endocrinology & Diabetes, 11/02/09

Freudenberg LS et al. – rhTSH or THW deliver statistically equivalent radiation doses to thyroid remnant and may be chosen based on safety, quality–of–life, convenience and pharmacoeconomic factors. Institutional fixed radioiodine activities formulated for use with THW need not be adjusted for rhTSH–aided ablation.

<< Previous
Bisphosphonate therapy: When not to monitor BMD

Next >>
Metabolism and Circadian Rhythms—Implications for Obesity

Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer
Thyroid, 10/30/09 Relevance Score: 68%

Amifostine for salivary glands in high-dose radioactive iodine treated differentiated thyroid cancer
Cochrane Reviews, 10/09/09 Relevance Score: 67%

Anaplastic thyroid cancer: Clinical outcomes with conformal radiotherapy
Head & Neck, 11/04/09 Relevance Score: 66%

124I PET-Based 3D-RD Dosimetry for a Pediatric Thyroid Cancer Patient: Real-Time Treatment Planning and Methodologic Comparison
The Journal of Nuclear Medicine, 11/03/09 Relevance Score: 65%

Growth inhibition of thyroid follicular cell-derived cancers by the opioid growth factor (OGF) - opioid growth factor receptor (OGFr) axis
BMC Cancer, 10/21/09 Relevance Score: 65%